Avery Schumacher

Nov 14, 2024 | jdsupra.com | Audrey Davis |Amy F. Lerman |Avery Schumacher

Since 2016, Epstein Becker Green (EBG) attorneys have researched, compiled, and analyzed state-specific content relating to the regulatory requirements for professional mental/behavioral health practitioners and stakeholders seeking to provide telehealth-focused services.

Nov 10, 2023 | jdsupra.com | Audrey Davis |Amy F. Lerman |Avery Schumacher

Since 2016, Epstein Becker Green (EBG) attorneys have researched, compiled, and analyzed state-specific content relating to the regulatory requirements for professional mental/behavioral health practitioners and stakeholders seeking to provide telehealth-focused services.

Nov 9, 2023 | healthlawadvisor.com | Amy F. Lerman |Audrey Davis |Avery Schumacher

Interest in and acceptance of telehealth services continues to grow. In 2023, a key focus by the states has been addressing questions about how to modify existing regulatory infrastructures sustaining the provision of telehealth services to support the continued use of these services in a post-public health emergency world. However, modifications to telehealth services also increases the potential for fraudulent behavior and enforcement activity.

Mar 7, 2023 | lexblog.com | Alan Arville |Delia Deschaine |Amy E. Lerman |Avery Schumacher

On February 24, 2023, the Drug Enforcement Agency (“DEA”) proposed permanent rules around prescribing controlled substances via telemedicine that expand the circumstances under which practitioners can prescribe controlled substances without first conducting an in-person medical evaluation of the patient outside of the COVID-19 public health emergency (“PHE”).